CClinicalTrials.gg
CompletedNCT03663972ARCUpdated Jun 18, 2020

Age-related Correlates of Treatment for Late-acquired Sounds

An interventional study of articulation therapy and phonologic treatment in Speech Sound Disorder, Phonology Disorder and Phonology Impairment, sponsored by University of Wyoming. Completed at 1 site in United States. Open to participants aged 4 Years to 8 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-06-18.

Sponsored by University of Wyoming · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Non-randomized
Ages
4 Years to 8 Years
Sex
All
01

Study summary

Late-acquired sounds, such as /r/ are difficult to learn and many children experience persistent errors on these sounds. The purpose of the present study is to determine whether treating these sounds earlier in the child's life may result in better outcomes.

Read the detailed description

Late-acquired sounds, such as /r/ are difficult to learn and many children experience persistent errors on these sounds. However, these sounds are often treated later in a child's life because they are not expected to be fully acquired until quite late--age 7-8 for some sounds. This practice places treatment in a time of the child's development in which they struggle to learn new sounds.The purpose of the present study is to determine whether treating these sounds earlier in the child's life may result in better outcomes, and to examine treatment efficacy and efficiency for two methods of treatment.

02

Conditions studied

  • Speech Sound Disorder
  • Phonology Disorder
  • Phonology Impairment
  • Phonological Disorder
  • Articulation Disorders in Children
  • Developmental Phonological Disorder
  • Speech Disorders
  • Speech Delay
  • Articulation Disorders, Developmental

Keywords

  • treatment
  • efficacy
  • efficiency
  • late-acquired sounds
03

Who can participate

Ages eligible
4 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Normal Hearing
  • Typical Receptive Language
  • Speech Sound Disorder
  • No motor speech impairment
  • Typical non-verbal intelligence
  • Produces at least one late-acquired sound with \<7% accuracy
  • Monolingual English-speaking
  • Typical in terms of motoric and neurological development

Exclusion criteria

Exclusionary Criteria:

  • Neurological disorder
  • Hearing loss
  • Nonverbal IQ \< 16th percentile
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Active comparator
    Motoric Arm

    Children will participate in an intervention based on traditional articulation approaches to speech therapy.

    Behavioral: articulation therapy

  • Active comparator
    Phonologic Arm

    Children will receive intervention that targets the conceptual representation of sounds.

    Behavioral: phonologic treatment

Interventions

  • Behavioralarticulation therapy

    children receive instruction in producing new sounds at the isolation, syllable and word level.

  • Behavioralphonologic treatment

    children receive instruction in producing new sounds at the word level

05

What researchers measure

Primary outcomes

  1. Treatment Efficacy: Number of correct productions of treated speech sounds in treatment words

    Accurate Production of treatment sound at baseline and at posttest

    Time frame: baseline until accuracy criterion is met; up to 18 weeks after final baseline session

  2. Treatment Efficiency: Number of sessions required to meet accuracy criteria

    Number of treatment sessions required to meet accuracy criteria (90% accuracy across three consecutive sessions or a maximum of 35 treatment sessions)

    Time frame: baseline until accuracy criterion is met; up to 18 weeks after final baseline session

  3. Session Length: Mean duration of sessions in minutes

    Start and end time of session is recorded on scoresheet, then number of minutes for each session for each participant is found and the mean across all sessions is calculated.

    Time frame: First treatment session until final treatment session. Final treatment session occurs when accuracy of treatment sound is met (90% accuracy across three consecutive sessions or a maximum of 35 treatment sessions)

Secondary outcomes

  1. Accuracy of production of untreated sounds measured on pretest and posttest probes

    Some children may generalize their skills learned through treatment to sounds that were not treated in the trial.

    Time frame: baseline and at posttest up to 18 weeks after final baseline session

06

Study locations

1 site
  • University of Wyoming
    Laramie, Wyoming 82071, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03663972
Lead sponsor
University of Wyoming
Responsible party
Breanna Irene Krueger (Assistant Professor, University of Wyoming) — Principal investigator
First posted
Sep 10, 2018
Start date
Jun 11, 2018
Primary completion
Apr 30, 2020
Completion
Apr 30, 2020
Last update
Jun 18, 2020

Study contacts

Breanna I. Krueger, PhD
principal investigator · University of Wyoming

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion